文献速递骨肌技术与安全CTDR

双能X线吸收法用于骨质疏松筛查:AJR专家小组叙述性综述

Dual-Energy X-Ray Absorptiometry for Osteoporosis Screening: AJR Expert Panel Narrative Review.
PubMed 文献 · AJR Am J Roentgenol · 2025-12-03

该AJR专家小组叙述性综述讨论双能X线吸收法(DXA)用于骨质疏松筛查的现状,涵盖当前实践推荐、骨密度结果指导风险预测与管理决策、报告与筛查建议、脆性骨折风险评估工具、骨小梁评分的作用、种族民族与性别考量、儿童应用及基于CT的骨密度测量与机会性筛查,并指出DXA仍未被充分利用且骨质疏松诊断不足。

要点

  • DXA除测量各解剖部位骨密度外,还可进行椎体骨折分析、骨小梁评分测定和全身成分分析。
  • 骨密度之外的性别、种族民族、既往脆性骨折、糖皮质激素使用和既往跌倒等因素影响骨折风险。
  • 尽管存在筛查建议,DXA仍未被充分利用,骨质疏松诊断不足。

核心结论

  • DXA是骨质疏松筛查和治疗监测的成熟方法,其结果可预测骨折风险,但该检查存在局限性,制定治疗和随访策略时须考虑骨密度测量之外的其他因素。

研究设计与样本

  • AJR专家小组叙述性综述,讨论DXA用于骨质疏松筛查的现状、当前实践推荐、骨密度结果指导风险预测与管理决策、挑战与局限性及不断演进的解决方案。

诊断标准与关键数值

  • DXA可测量各解剖部位骨密度,并可行椎体骨折分析、骨小梁评分测定和全身成分分析。
  • 性别、种族和民族、既往脆性骨折、糖皮质激素使用和既往跌倒影响骨折风险。

临床应用与阅片要点

  • 综述涵盖DXA报告与筛查建议、脆性骨折风险评估工具、骨小梁评分的作用、种族民族与性别考量、儿童应用以及基于CT的骨密度测量和机会性筛查。

局限性

  • DXA虽在骨质疏松筛查中居核心地位,但该检查存在局限性。
  • 尽管老年人口不断增长且骨折风险变异证据不断增加,骨质疏松筛查建议尚未显著演变。
  • 尽管存在筛查建议,DXA仍未被充分利用,骨质疏松诊断不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Dual-energy x-ray absorptiometry (DXA) is an established method for osteoporosis screening and treatment monitoring, providing results that predict fracture risk. DXA is used not only to measure bone mineral density (BMD) in various anatomic sites, but also to perform vertebral fracture analysis, trabecular bone score (TBS) determination, and whole-body composition analysis. Although DXA is central in osteoporosis screening, the test has limitations, and other factors beyond BMD measurements must be considered when planning treatments and follow-up strategies. For example, sex, race and ethnicity, prior fragility fractures, glucocorticoid use, and prior falls affect fracture risk. Despite a growing population of older individuals and growing evidence of variations in fracture risk, osteoporosis screening recommendations have not evolved significantly. Moreover, despite the existence of screening recommendations, DXA remains underutilized, and osteoporosis is underdiagnosed. This AJR Expert Panel Narrative Review discusses the current status of osteoporosis screening by DXA, addressing current practice recommendations, the use of BMD results to guide risk predictions and management decisions, as well as the challenges and limitations along with evolving solutions. Topics explored include DXA reporting and screening recommendations; fragility fracture risk assessment tools; the role of TBS; race, ethnicity, and sex considerations; application in children; and CT-based BMD measurements and opportunistic screening.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Aparisi Gómez MP, Wáng YJ, Yu JS, et al. Dual-Energy X-Ray Absorptiometry for Osteoporosis Screening: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2025. PMID: 40366788. doi:10.2214/AJR.25.32802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。